We are live on
!
Find out more
SM
Selkirk Management Portfolio holdings
AUM
$294M
1-Year Est. Return
26.84%
This Fund
S&P 500
This Quarter
Est. Return
+11.18%
1 Year Est. Return
+26.84%
3 Year Est. Return
+268.17%
5 Year Est. Return
+149.88%
10 Year Est. Return
+942.58%
AUM
$177M
AUM Growth
+$19.4M
(+12%)
Cap. Flow
+$2.67M
Cap. Flow
% of AUM
1.51%
Top 10 Holdings %
Top 10 Hldgs %
76.56%
Holding
21
New
3
Increased
2
Reduced
6
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$9.58M |
| 2 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$2.95M |
| 3 |
AXDX
Accelerate Diagnostics
AXDX
|
+$1.01M |
| 4 |
Zillow
ZG
|
+$873K |
| 5 |
Zillow
Z
|
+$356K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.16M |
| 2 |
Corpay
CPAY
|
+$2.23M |
| 3 |
Equinix
EQIX
|
+$1.94M |
| 4 |
Charter Communications
CHTR
|
+$1.91M |
| 5 |
Bausch Health
BHC
|
+$1.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.49% |
| 2 | Consumer Discretionary | 19.23% |
| 3 | Real Estate | 14.71% |
| 4 | Communication Services | 14.51% |
| 5 | Financials | 7.12% |
Similar funds
BIC
TJHA
PC
MFC
PCI
DMBA
KNFPWM
MEPT
Selkirk Management's Q1 2017 Portfolio in Review
As of Q1 2017, Selkirk Management held 21 positions worth $177M, up 12% from $157M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Selkirk Management's Q1 2017 filing shows 3 new, 2 increased, 6 reduced and 1 closed positions. Its largest new stake was Invesco QQQ Trust: 75,000 shares worth $9.93M. The largest sale was Gilead Sciences, an estimated $3.16M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Real Estate.
- Selkirk Management's largest Q1 2017 buy was Invesco QQQ Trust: 75,000 shares worth $9.93M.
- Selkirk Management added most to Accelerate Diagnostics in Q1 2017, an estimated $1.01M increase.
- Selkirk Management's biggest Q1 2017 reduction was Gilead Sciences, cutting an estimated $3.16M.
- Selkirk Management fully exited Bausch Health in Q1 2017, selling an estimated $1.48M.
- Selkirk Management's ten largest holdings make up 77% of its $177M portfolio in Q1 2017.
- Selkirk Management opened 3 new positions and closed 1 in Q1 2017.
- Selkirk Management's portfolio value rose 12% quarter-over-quarter to $177M.
Based on Selkirk Management's 13F filing for Q1 2017, filed 15 May 2017.